Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Health Park Co. Ltd. currently has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This case is assigned to ALAM, DANYAL HASSAN, who is the busiest examiner for the company. The portfolio's active workload is concentrated under 1 distinct examiner and a single distinct art unit.
This suggests a targeted approach to its current biotech-related filings. The resolution of the 1 pending office action will be the primary factor in the company's near-term success within this technology area. Practitioners should analyze the specific history of ALAM, DANYAL HASSAN to optimize the response for the active matter.
The concentration in a single art unit indicates a specialized technical focus that has not yet branched into broader pharmaceutical disciplines. Because the entire active workload resides with an individual examiner, the firm's strategy is highly sensitive to the specific requirements of that official. Future filings may eventually diversify the portfolio across more units as the company expands its intellectual property footprint.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ALAM, DANYAL HASSAN | 1 | 66.7% | +0.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18262327 | VIRUS-LIKE PARTICLE COMPRISING TOXOPLASMA GONDII PROTEIN AND INFLUENZA VIRUS PROTEIN, AND DIAGNOSTIC METHOD USING SAME | ALAM, DANYAL HASSAN | — |
| Art Unit | Apps |
|---|---|
| 1672 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18262327 | VIRUS-LIKE PARTICLE COMPRISING TOXOPLASMA GONDII PROTEIN AND INFLUENZA VIRUS PROTEIN, AND DIAGNOSTIC METHOD USING SAME | ALAM, DANYAL HASSAN | 1672 | §102§103§112 | Final Rejection | — | Pending | Jul 20, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialHealth Park Co. Ltd. has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Danyal Hassan Alam has the most, with 1 of Health Park Co. Ltd.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
